Heritability of Low ER Staining/HER2-Breast Tumors: Are We Missing an Opportunity for Germline Testing?
In 2010, the genetic testing criteria was changed to allow women diagnosed ≤ 60 years old with triple negative breast cancer (TNBC) to undergo germline testing. In the same year, estrogen receptor (ER) positivity was defined as having ≥1% ER staining cells. While tumors with 1–10% ER staining cells...
Main Authors: | Leann A. Lovejoy, Clesson E. Turner, Justin M. Wells, Craig D. Shriver, Rachel E. Ellsworth |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-12-01
|
Series: | Genes |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4425/11/12/1469 |
Similar Items
-
Indian Data on HER2 Fluorescence In Situ Hybridization in Invasive Breast Cancer with Immunohistochemically Equivocal Results As Per 2018 ASCO/CAP Guidelines
by: B. R. Nagarjun, et al.
Published: (2022-10-01) -
HER2 status in breast cancer: changes in guidelines and complicating factors for interpretation
by: Soomin Ahn, et al.
Published: (2020-01-01) -
Aktivnosti največjega mednarodnega strokovnega združenja onkologov ASCO in pogled na srečanje ASCO 2011
by: Tanja Čufer
Published: (2011-12-01) -
Recomendações para o seguimento do doente tratado por cancro colorectal
by: Nuno Matos Costa, et al.
Published: (2004-03-01) -
La fuerza del asco. Emociones y poder en La tiranía de las moscas de Elaine Vilar Madruga
by: Raquel Mosqueda Rivera
Published: (2023-03-01)